Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2014 | 67 | |||
Comparative effectiveness and cost-effectiveness assessment of erlotinib vs. gefitinib in first-line treatment of EGFR activating mutation positive non-small cell lung cancer for Hong Kong Proceeding/Conference:ISPOR 2012 Asia-Pacific Conference | 2012 | 25 |